LEO Pharma’s Anzupgo (delgocitinib) cream has been approved by the US Food and Drug Administration (FDA) to treat adults with ...

LEO Pharma, a global leader in medical dermatology, announced today that the U.S. Food and Drug Administration (FDA) ha ...

Medicare drug plans may cover Rinvoq, but the specifics of coverage and out-of-pocket costs can differ depending on a person's specific plan.

LEO Pharma Inc. announced today that the Food and Drug Administration (FDA) has approved ANZUPGO® (delgocitinib) cream for ...

Cytokine networks demonstrate dual functionality. Cytokines are key regulators of immune homeostasis, but paradoxically, cytokines also function as pathogenic drivers in diseases such as systemic ...

The rapidly increasing prescriptions for expensive specialty medications, rather than their price growth, are the primary ...